Overview
Funding Rounds 1
| Date | Series | Amount | Investors |
| Sign up to see | Sign up to see | Sign up to see | Sign up to see |
Mentions in press and media 3
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Jan 22, 2024 | Bolden Therapeutics Closes $1.5M in Pre-Seed Convertible Note Financing | Bolden Therapeutics, Inc., a Providence, R.I.-based biotechnology company developing first-in-class therapeutics to promote neurogenesis for the potential treatment of central nervous system illnesses such as Alzheimer’s disease, closed a $... |
| Jan 9, 2024 | Bolden Therapeutics Receives Investment From Lifespan Vision Ventures | Lifespan Vision Ventures invests in Bolden Therapeutics Bolden Therapeutics, a Providence, RI-based company developing therapeutics to promote neurogenesis for the potential treatment of central nervous system diseases, received an investme... |
Reviews 0
FAQ about Bolden Therapeutics
How much funding has Bolden Therapeutics raised?
Bolden Therapeutics has raised $1.5M in total across 1 funding round.
What has the press written about Bolden Therapeutics?
Parsers VC has collected 3 articles mentioning Bolden Therapeutics, among them “Bolden Therapeutics Closes $1.5M in Pre-Seed Convertible Note Financing” (Jan 22, 2024) and “Bolden Therapeutics Receives Investment From Lifespan Vision Ventures” (Jan 9, 2024).
Is Bolden Therapeutics still active?
Yes, Bolden Therapeutics is active; its latest activity on Parsers VC dates from Jul 10, 2024.